ID

42266

Description

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin); ODM derived from: https://clinicaltrials.gov/show/NCT00890006

Link

https://clinicaltrials.gov/show/NCT00890006

Keywords

Versions (3)
  1. 5/13/17 5/13/17 -
  2. 4/10/21 4/10/21 - Ahmed Rafee, MD
  3. 4/26/21 4/26/21 - Sarah Riepenhausen
Copyright Holder

MDM

Uploaded on

April 26, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006

English

Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
low or intermediate risk localized prostate cancer:
Description

localized prostate cancer

Data type

boolean

Alias
UMLS CUI [1]
C0600139
gleason score ≤ 7
Description

gleason score

Data type

boolean

Alias
UMLS CUI [1]
C0332326
psa <20
Description

psa

Data type

boolean

Alias
UMLS CUI [1]
C0138741
stage t2a or less (stage 2 only)
Description

prostate cancer stage

Data type

boolean

Alias
UMLS CUI [1]
C0280280
<50% of biopsy cores involved with tumor (stage 2 only)
Description

prostate cancer biopsy histology

Data type

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0005558
UMLS CUI [1,3]
C0019638
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of hip replacement
Description

hip replacement

Data type

boolean

Alias
UMLS CUI [1]
C0392806
inflammatory bowel disease or collagen vascular disease
Description

inflammatory bowel disease, collagen vascular disease

Data type

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0262428
contraindication to fiducial marker placement
Description

fiducial markers contraindication

Data type

boolean

Alias
UMLS CUI [1,1]
C2826325
UMLS CUI [1,2]
C1301624
bleeding diathesis or anticoagulant therapy that cannot safely be ceased temporarily
Description

bleeding diathesis, anticoagulant therapy

Data type

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0150457
severe adverse event with prior trus-guided prostate biopsy
Description

trus- guided prostate biopsy adverse event

Data type

boolean

Alias
UMLS CUI [1,1]
C0194804
UMLS CUI [1,2]
C0373345
UMLS CUI [1,3]
C0877248
patient refuses fiducial marker placement
Description

patient refuses fiducial markers

Data type

boolean

Alias
UMLS CUI [1,1]
C2826325
UMLS CUI [1,2]
C3242233
contraindication to mri
Description

mri contraindication

Data type

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C0522473
patient randomization in profit trial (stage 2 only)
Description

patient randomization

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0034656
patients not prescribed 78gy in 39 fractions to the prostate gland.
Description

prostate radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0948317
Back to the top of the page

Similar models

Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
localized prostate cancer
Item
low or intermediate risk localized prostate cancer:
boolean
C0600139 (UMLS CUI [1])
gleason score
Item
gleason score ≤ 7
boolean
C0332326 (UMLS CUI [1])
psa
Item
psa <20
boolean
C0138741 (UMLS CUI [1])
prostate cancer stage
Item
stage t2a or less (stage 2 only)
boolean
C0280280 (UMLS CUI [1])
prostate cancer biopsy histology
Item
<50% of biopsy cores involved with tumor (stage 2 only)
boolean
C0600139 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
hip replacement
Item
history of hip replacement
boolean
C0392806 (UMLS CUI [1])
inflammatory bowel disease, collagen vascular disease
Item
inflammatory bowel disease or collagen vascular disease
boolean
C0021390 (UMLS CUI [1])
C0262428 (UMLS CUI [2])
fiducial markers contraindication
Item
contraindication to fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
bleeding diathesis, anticoagulant therapy
Item
bleeding diathesis or anticoagulant therapy that cannot safely be ceased temporarily
boolean
C0005779 (UMLS CUI [1])
C0150457 (UMLS CUI [2])
trus- guided prostate biopsy adverse event
Item
severe adverse event with prior trus-guided prostate biopsy
boolean
C0194804 (UMLS CUI [1,1])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
patient refuses fiducial markers
Item
patient refuses fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C3242233 (UMLS CUI [1,2])
mri contraindication
Item
contraindication to mri
boolean
C0024485 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
patient randomization
Item
patient randomization in profit trial (stage 2 only)
boolean
C0030705 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
prostate radiotherapy
Item
patients not prescribed 78gy in 39 fractions to the prostate gland.
boolean
C0948317 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial